FDA orders blindness risk warning on weight loss drugs
Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration (FDA) has said.
We haven't written up this one. Sky News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.